Patent · US Active

Site-specific enzymes and methods of use

US10415024B2 · kind B2 · utility

2Cited by

40References

8Claims

0Family size

Assignee

Poseida Therapeutics, Inc. · US

Inventors

Eric M. Ostertag · San Diego, US
Tseten Yeshi · San Diego, US

Key dates

Filing date	Nov 18, 2013
Grant date	Sep 17, 2019
Priority date	—
Expiry date	Nov 18, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/195
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention provides polypeptides related to Ralstonia proteins, nucleic acids encoding the same, compositions comprising the same, kits comprising the same, non-human transgenic animals comprising the same, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.